Department of Health and Human Services March 3, 2008 – Federal Register Recent Federal Regulation Documents

Advisory Committee on Childhood Lead Poisoning Prevention
Document Number: E8-4085
Type: Notice
Date: 2008-03-03
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Organ Procurement and Transplantation Network
Document Number: E8-3994
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, Health Resources and Services Administration
HRSA, Healthcare Systems Bureau, Division of Transplantation (DoT) is in the process of information- gathering to assist in determining whether it should engage in rulemaking with respect to vascularized composite allografts, described more fully below. The purpose of this solicitation is to receive feedback from stakeholders and the public on the following questions: (1) Whether vascularized composite allografts should be included within the definition of organs covered by the regulations governing the operation of the Organ Procurement and Transplantation Network (OPTN) (referred to here as the ``final rule''), and regulated as such, and the likely impact of such an amendment; (2) whether vascularized composite allografts should be added to the definition of human organs covered by section 301 of the National Organ Transplant Act of 1984, as amended, (NOTA) and the likely impact of such an addition; and (3) if either of these changes are pursued, the optimal way to define vascularized composite allografts for the above-described purposes. This Request for Information is limited to information-gathering and is not a proposal to make any determinations regarding Federal oversight of vascularized composite allografts.
Draft Guidance for Industry on Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention; Availability
Document Number: E8-3974
Type: Notice
Date: 2008-03-03
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention.'' The draft guidance provides recommendations for industry for developing drugs and therapeutic biologics for the prevention and treatment of diabetes mellitus. Because diabetes mellitus has reached epidemic proportions in the United States, FDA recognizes the need for new products that can be used as part of a comprehensive treatment strategy in the treatment and prevention of diabetes. In addition to the draft guidance, FDA plans to convene a public advisory committee meeting to specifically discuss new approaches for the development of products for the treatment of diabetes, with particular emphasis on the design and implementation of studies to assess long-term cardiovascular risks and benefits of these new products. FDA plans to announce the meeting date in a future issue of the Federal Register.
National Institute of Mental Health; Notice of Closed Meeting
Document Number: 08-909
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Document Number: 08-908
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Institute On Aging; Amended Notice of Meeting
Document Number: 08-907
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Document Number: 08-906
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings
Document Number: 08-905
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 08-904
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Eye Institute; Notice of Closing Meetings
Document Number: 08-903
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
Document Number: 08-902
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
National Institute On Deafness and Other Communication Disorders; Notice of Meeting
Document Number: 08-901
Type: Notice
Date: 2008-03-03
Agency: Department of Health and Human Services, National Institutes of Health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.